Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C

Daclatasvir (Daklinza™), a new oral direct-acting antiviral, is an inhibitor of hepatitis C virus NS5A protein and has recently been approved in the United States, Europe and Japan in chronic hepatitis C. It shows potent pangenotypic activity and moderately high genetic barrier to resistance improvi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Gastroenterol
Main Authors: Manolakopoulos, Spilios, Zacharakis, George, Zissis, Miltiadis, Giannakopoulos, Vassilis
Format: Artigo
Sprog:Inglês
Udgivet: Hellenic Society of Gastroenterology 2016
Fag:
Review Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4923813/
https://ncbi.nlm.nih.gov/pubmed/27366028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2016.0041
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker